Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis

Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis

Aim: To assess the ability of signature metabolites alone, or in combination with the model for end-stage liver disease-Na (MELD-Na) score to predict mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis. Materials & methods: Plasma metaboli...

Full description

Saved in:
Bibliographic Details
Main Authors: Ayse L Mindikoglu, Cristian Coarfa, Antone R Opekun, Vijay H Shah, Juan P Arab, Konstantinos N Lazaridis, Nagireddy Putluri, Chandrashekar R Ambati, Matthew J Robertson, Sridevi Devaraj, Prasun K Jalal, Abbas Rana, John A Goss, Thomas C Dowling, Matthew R Weir, Stephen L Seliger, Jean-Pierre Raufman, David W Bernard, John M Vierling
Format: Article
Language:English
Published: Taylor & Francis Group 2020-02-01
Series:Future Science OA
Subjects:
biomarker
cirrhosis
liver transplantation
MELD-Na score
metabolite
metabolomics
Online Access:https://www.future-science.com/doi/10.2144/fsoa-2019-0124
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items